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The larynx is an extremely rare site of involvement by lymphomatous disease.We present two cases of isolated laryngeal high-grade
and another low-grade lymphoma, together with a literature review of laryngeal lymphoma management.
1. Case 1
An 82-year-old Caucasian lady known to suffer from ischa-
emic heart disease, hypertension, and mild renal impairment
was admitted to hospital in November 2010 complaining
of a 3-month history of increasing facial pain and dif-
ficulty breathing. She had previously undergone surgery
for a complicated diverticular abscess two years prior to
this presentation and this had resulted in a defunctioning
colostomy. Physical examination showed no lymphadenopa-
thy or organomegaly. Indirect laryngoscopy showed a mass
at the base of the tongue, involving the epiglottis and causing
airway obstruction. The patient underwent an emergency
tracheostomy to secure the airway. Investigations showed a
white blood count of 11.3 × 109/L, haemoglobin of 104 g/L,
platelets of 296 × 109/L, and a normal serum lactate dehy-
drogenase level of 209U/L. Staging with computed tomog-
raphy only confirmed disease in the laryngeal area (Figure 1)
and did not show any thoracic, abdominal, or pelvic lym-
phadenopathy. Bone marrow aspiration and biopsy showed
no evidence of bone marrow involvement.
Biopsy of the laryngeal mass showed that the mucosa
and submucosa were infiltrated by large atypical lymphoid
cells with irregular nuclear outlines and multiple prominent
nucleoli.The cells were positive for CD45 and CD20 and neg-
ative for CD3 and bcl2 on immunohistochemistry (Figure 2).
These findings were consistent with a diagnosis of diffuse
large B-cell (high-grade) non-Hodgkin lymphoma of the
larynx, stage IE, with an R-IPI score of 1 (age > 60, ECOG
0–2, normal LDH of 209U/L, 0-1 extranodal sites, and stage
I/II disease).
The patient was administered three cycles of R-CEOP
(rituximab, cyclophosphamide, etoposide, vincristine, and
prednisone) followed by involved field radiotherapy. Anthra-
cyclines were avoided in view of a decreased left ventricular
ejection fraction of 40% on echocardiography performed at
diagnosis.
The first cycle of chemotherapy was complicated by an
acute coronary syndrome, from which the patient recovered
with supportive care.The tracheostomy was removed follow-
ing the second cycle of cytotoxics and the patient remains
alive and well 5 years later.
2. Case 2
A 65-year-old Caucasian gentleman, with a history of
ischaemic heart disease, presented to ENT with a two-
month history of hoarseness. Physical examination was
unremarkable, with no lymphadenopathy or organomegaly.
Investigations showed a white blood count of 5.7 × 109/L,
haemoglobin of 148 g/L, platelets of 213 × 109/L, and a normal
serum lactate dehydrogenase level of 192U/L.
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Figure 1: Computed tomography at presentation.
Indirect laryngoscopy showed vocal polyps, which were
excised. Histology showed a monotonous population of lym-
phoid cells within the lamina propria of mucosal polyps, with
slightly irregular nuclear contours and inconspicuous to clear
cytoplasm. Immunohistochemistry was positive for CD45,
CD20, and bcl2 and negative for CD5, CD23, bcl6, CD138,
CD43, CD10, and cyclin D1 (Figure 3), consistent with a
diagnosis of extranodal marginal zone (low-grade) non-
Hodgkin lymphoma.
Staging with computed tomography and bone marrow
aspiration and biopsy showed no evidence of disease involve-
ment outside of the larynx.
Thepatient wasmanagedwith involved field radiotherapy
to the larynx with clinical resolution of symptoms and no
radiological evidence of residual disease. He remains alive
and well 5 years later.
3. Discussion
Extranodal lymphomas confined to the larynx are rare,
accounting for <1% of all laryngeal neoplasms, with only
about 100 cases having been described in the literature to date
[1]. A ten-year review involving 2631 laryngeal biopsies in a
large Spanish hospital revealed only one case of diffuse large B
cell lymphoma [2].This rare occurrence is due to the relatively
low lymphoid content in the larynx when compared to other
areas in the respiratory tract. The mean age at diagnosis is 70
years, with a range from 4 to 81 years. The male : female ratio
has been reported to be variable in different series [3–5].
Laryngeal lymphoma presents clinically in a similar
fashion to squamous cell carcinoma, with symptoms such as
hoarseness, dyspnoea, a foreign body sensation in the throat,
or stridor. Uncommonly, it may present catastrophically
with acute airway obstruction requiring immediate surgical
intervention, as in Case 1 presented above. Systemic symp-
tomatology is unusual, since laryngeal lymphomas tend to
remain localized for prolonged periods, thoughmore aggres-
sive forms tend to spread earlier [6]. Interestingly, these
tumors usually spread to other mucosal sites such as bowel,
lung, and orbit rather than nodal sites [7, 8].
The commonest anatomical site involved is the supraglot-
tic region (47%), with glottic involvement accounting for 25%
of cases.The transglottic and subglottic regions are much less
commonly affected [6].
Macroscopically, these tumors present as smooth or poly-
poid masses as depicted in our two cases, respectively, rather
than ulcerated masses [6]. In fact, both the macroscopic and
radiological appearances of a large laryngeal tumour with a
supraglottic submucosal component should alert the report-
ing investigators to the possibility of laryngeal lymphoma [3–
5], though the definite diagnosis always rests on histology.
Histologically, primary laryngeal lymphoma is more com-
monly of B-cell origin, though some T-cell and NK-cell lym-
phomas may occur. The latter are more difficult to diagnose
and usually require deep and sometimes repeated biopsy.
This latter subgroup of laryngeal lymphoma is commoner in
HIV patients.The B-cell to T/NK-cell Lymphoma ratio is 6 : 1
[1, 5, 7].
There is some emerging evidence in the literature of the
association ofH. pylori and other urease-splitting organisms,
which may colonize the larynx, and the development of
Primary Marginal Zone Laryngeal Lymphoma. When inves-
tigating Primary Marginal Zone Laryngeal Lymphoma one
should also exclude autoimmune conditions such as Sjo¨gren’s
syndrome [7, 8].
It is imperative to stage the lymphomatous process cor-
rectly, since treatment varies depending on both the grade
and the stage of the disease. PET-CT, in particular, is finding
an important place for radiological staging in laryngeal lym-
phoma, both low-grade and high-grade [9, 10]. In our cases
we did not perform PET-CT since these cases predated the
advent of this radiological modality in our country.
A review of the literature on isolated laryngeal lym-
phomas published over the last 2 years (from 1994–2014)
mainly revealed case reports and reviews. No specific studies
have been carried out specifically looking at the management
of this rare type of lymphoma.Most reports described cases of
MALT lymphomas as in our Case 2 and others related to
T/NK lymphomas [11]. Therapy was nonhomogenous due to
the different types of lymphomas as well as small numbers.
However, the main modalities of treatment were IFRT (30–
50G) alone or in combination with chemotherapy. We opted
for 3 cycles of chemoimmunotherapy for Case 1 with DLBCL
and IFRT in Case 2 with MALT according to international
guidelines on limited stage disease [12]. Surgical intervention
is only usually required in cases presenting with acute airway
obstruction [6]. This disparity in treatment modalities, inde-
pendent of lymphoma histology, is depicted in a table of case
series reports found in the literature, spanning the period
of 1986 to 2013, presented by Bayoumi et al. [11]. A combined
chemotherapy-radiotherapy, seems to be, however, the
emerging preferred modality of treatment, especially for
high-grade lymphomas [6, 11].
From this review, the most important points to emerge
are as follows.
(1) One should have a high index of suspicion for lym-
phoma of the larynx, since the management is very
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Figure 2: Infiltrate of vocal cord by large lymphoid cells on H&E ((a) and (b)), positive for CD20 ((c) and (d)) on immunohistochemistry.
(a) (b)
(c) (d)
Figure 3: Infiltrate of vocal cord by small sized lymphoid cells on H&E ((a) and (b)), positive for CD20 (c) and bcl-2 (d) on
immunohistochemistry.
different from that of other more commonly occur-
ring tumors at this site.
(2) Due to the small number of cases reported, there is
no definite consensus regarding best management of
laryngeal lymphoma; it would be advisable that for the
time being one follows international lymphoma
guidelines on limited stage disease for the manage-
ment of laryngeal lymphoma [12].
(3) The discussions ensuing from case reports regarding
lymphoma affecting unusual sites highlight the lack of
evidence regarding the actual biology of these tumors
and best treatment options for patients.Thismay spur
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the formation of regional/international databases for
the description of lymphomas affecting specific un-
usual sites. With this approach these cases may be
studied in greater depth and may prompt the devel-
opment of comparative treatment trials, provid-
ing patients with more evidence-based therapeutic
modalities.
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